NCT04296149View on ClinicalTrials.gov

Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe

PHASE2CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 16, 2017

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2019

Conditions
Neuroendocrine Tumors
Interventions
DRUG

Y90-DOTA-Tyr3-Octreotide

Patients enrolled for surgery will receive a small amount of Y-90-DOTATOC, in order to check beta- radioactivity by the probe

Trial Locations (1)

20141

Chiara Maria Grana, Milan

All Listed Sponsors
lead

European Institute of Oncology

OTHER

NCT04296149 - Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe | Biotech Hunter | Biotech Hunter